| Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference |
RADNOR, Pa. , May 16, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Brent Jones, Executive Vice President and Chief Financial Officer, will be participating in a fireside chat at the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025 at approximately 8:00 a.m. |
prnewswire.com |
2025-05-16 12:30:00 |
Czytaj oryginał (ang.) |
| Avantor® to Participate in Bank of America Securities 2025 Health Care Conference |
RADNOR, Pa. , May 2, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Bank of America Securities 2025 Health Care Conference in Las Vegas on Tuesday, May 13, 2025 at approximately 10:00 a.m. |
prnewswire.com |
2025-05-02 12:05:00 |
Czytaj oryginał (ang.) |
| Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y |
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures. |
zacks.com |
2025-04-28 16:25:41 |
Czytaj oryginał (ang.) |
| Avantor Analysts Cut Their Forecasts After Q1 Results |
Avantor Inc AVTR reported in-line earnings for its first quarter on Friday. |
benzinga.com |
2025-04-28 13:28:00 |
Czytaj oryginał (ang.) |
| Avantor: A Healthier Diagnosis As Expectations Cool |
Avantor's shares have nearly halved since October, driven by lackluster organic growth, elevated debt, and a mixed financial track record. The company operates in two segments, generating nearly $7 billion in sales, with significant exposure to laboratory solutions and bioscience production. Despite a reduction in net debt and lower earnings multiples, the business faces ongoing challenges, including flat organic growth and a high leverage ratio. |
seekingalpha.com |
2025-04-26 09:01:50 |
Czytaj oryginał (ang.) |
| Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift |
Avantor Inc AVTR on Friday reported adjusted EPS of 23 cents in line with consensus. |
benzinga.com |
2025-04-25 16:24:25 |
Czytaj oryginał (ang.) |
| Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut |
Avantor (AVTR) shares sank 16% Friday after the maker of lab chemicals and other life sciences products announced its CEO was resigning, reported weaker-than-expected net sales as government spending fell, and slashed its guidance. |
investopedia.com |
2025-04-25 15:11:25 |
Czytaj oryginał (ang.) |
| Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript |
Avantor, Inc. (NYSE:AVTR ) Q1 2025 Earnings Call April 25, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications and Brand Michael Stubblefield - President and CEO R. Brent Jones - EVP and CFO Conference Call Participants Michael Ryskin - Bank of America Securities Vijay Kumar - Evercore ISI Rachel Vatnsdal - J.P. |
seekingalpha.com |
2025-04-25 14:53:59 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Avantor (AVTR) Q1 Earnings: A Look at Key Metrics |
While the top- and bottom-line numbers for Avantor (AVTR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-04-25 14:35:44 |
Czytaj oryginał (ang.) |
| Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates |
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.23 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.22 per share a year ago. |
zacks.com |
2025-04-25 12:15:32 |
Czytaj oryginał (ang.) |
| Avantor® Announces CEO Transition |
Board initiates search process to identify next CEO RADNOR, Pa. , April 25, 2025 /PRNewswire/ -- Avantor, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, today announced that Michael Stubblefield intends to step down from his role as Director, President and Chief Executive Officer upon the appointment of a successor. |
prnewswire.com |
2025-04-25 10:07:00 |
Czytaj oryginał (ang.) |
| Avantor® Reports First Quarter 2025 Results |
Net sales of $1.58 billion, decrease of 6%; organic decline of 2% Net income of $64.5 million; Adjusted EBITDA of $269.5 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.23 Operating cash flow of $109.3 million; free cash flow of $82.1 million Announces significant actions across the business to accelerate growth and enhance cost structure; increasing cost transformation target to $400 million in gross run-rate savings exiting 2027 RADNOR, Pa. , April 25, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2025. |
prnewswire.com |
2025-04-25 10:05:00 |
Czytaj oryginał (ang.) |
| Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX |
Industry leading set of technologies to drive scalability, flexibility, and efficiency in biologics production RADNOR, Pa. , April 1, 2025 /PRNewswire/ -- Avantor®, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, announces its presence at INTERPHEX, the premier annual gathering of pharmaceutical, biotechnology, and device development and manufacturing professionals. |
prnewswire.com |
2025-04-01 12:05:00 |
Czytaj oryginał (ang.) |
| Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025 |
RADNOR, Pa. , March 28, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2025 financial results before the market opens on Friday, April 25, and will hold a conference call to discuss the results on the same day at 8:00 a.m. |
prnewswire.com |
2025-03-28 10:05:00 |
Czytaj oryginał (ang.) |
| Here's Why You Should Hold AVTR Stock in Your Portfolio for Now |
Avantor is set for growth with a strong portfolio and solid fourth quarter results, but challenges like customer losses and forex volatility pose potential risks. |
zacks.com |
2025-03-27 13:30:29 |
Czytaj oryginał (ang.) |
| Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025 |
Facility in Gliwice, Poland to boost biopharma manufacturers' efficiency and speed to market of therapies RADNOR, Pa. , March 17, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology industries, announces that Ger Brophy, PhD, head of Avantor's Scientific Advisory Board, will present highlights of the recently completed expansion at its flagship European manufacturing site at Drug, Chemical & Associated Technologies Association (DCAT) Week 2025. |
prnewswire.com |
2025-03-17 09:05:00 |
Czytaj oryginał (ang.) |
| Avantor® to Present at TD Cowen's 45th Annual Health Care Conference |
RADNOR, Pa. , Feb. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will present at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, at 11:50 a.m. |
prnewswire.com |
2025-02-19 10:05:00 |
Czytaj oryginał (ang.) |
| Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology |
SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE: AVTR), and a leading global supplier of high-quality silicones for long-term medical implants, have entered into an agreement to facilitate the utilization of Silq's zwitterionic surface treatment technology on medical devices manufactured with NuSil silicone products. Zwitterion surface technolog. |
businesswire.com |
2025-02-19 10:03:00 |
Czytaj oryginał (ang.) |
| Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand |
Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance. |
zacks.com |
2025-02-10 14:46:15 |
Czytaj oryginał (ang.) |
| Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript |
Avantor, Inc. (NYSE:AVTR ) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent Jones - EVP and CFO Conference Call Participants Vijay Kumar - Evercore ISI Michael Ryskin - Bank of America Daniel Brennan - TD Cowen Rachel Vatnsdal - JP Morgan Tycho Peterson - Jefferies Luke Sergott - Barclays Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Conor McNamara - RBC Capital Markets Ivy Ma - Goldman Sachs Brandon Couillard - Wells Fargo Jack Meehan - Nephron Research Operator Hello everybody and a warm welcome to Avantor's Fourth Quarter 2024 Earnings Call. My name is Emily and I'll be coordinating your call today. |
seekingalpha.com |
2025-02-07 13:08:57 |
Czytaj oryginał (ang.) |
| Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates |
Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-02-07 12:31:43 |
Czytaj oryginał (ang.) |
| Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025 |
On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion. |
benzinga.com |
2025-02-07 11:15:02 |
Czytaj oryginał (ang.) |
| Avantor, Inc. (AVTR) Surpasses Q4 Earnings Estimates |
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago. |
zacks.com |
2025-02-07 10:16:19 |
Czytaj oryginał (ang.) |
| Avantor® Reports Fourth Quarter and Full Year 2024 Results |
Fourth Quarter 2024 Net sales of $1.69 billion, decrease of 2%; organic growth of 1% Net income of $500.4 million; Adjusted EBITDA of $307.7 million Diluted GAAP EPS of $0.73; adjusted EPS of $0.27 Operating cash flow of $173.3 million; free cash flow of $222.1 million Full Year 2024 Net sales of $6.78 billion, decrease of 3%; organic decline of 2% Net income of $711.5 million; Adjusted EBITDA of $1,198.8 million Diluted GAAP EPS of $1.04; adjusted EPS of $0.99 Operating cash flow of $840.8 million; free cash flow of $768.3 million RADNOR, Pa. , Feb. 7, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its fourth fiscal quarter and year ended December 31, 2024. |
prnewswire.com |
2025-02-07 08:05:00 |
Czytaj oryginał (ang.) |
| TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe |
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, to expand availability of its innovative nucleic acid products to customers across Europe, Middle East, and Africa (EMEA). This distribution pa. |
businesswire.com |
2025-02-03 08:00:00 |
Czytaj oryginał (ang.) |
| MD vs. AVTR: Which Stock Is the Better Value Option? |
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors? |
zacks.com |
2025-01-13 14:41:13 |
Czytaj oryginał (ang.) |
| Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025 |
RADNOR, Pa. , Jan. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Friday, February 7, and will hold a conference call to discuss the results on the same day at 8:00 a.m. |
prnewswire.com |
2025-01-10 10:05:00 |
Czytaj oryginał (ang.) |
| Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference |
RADNOR, Pa. , Jan. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will present at the 43rd Annual J.P. |
prnewswire.com |
2025-01-03 10:05:00 |
Czytaj oryginał (ang.) |
| MD vs. AVTR: Which Stock Should Value Investors Buy Now? |
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2024-12-27 14:40:22 |
Czytaj oryginał (ang.) |
| Avantor: Durable FCF Generator Trading For Cheap |
Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor's leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansion. Significant FCF generation can improve the company's capital structure and return value to shareholders. |
seekingalpha.com |
2024-12-18 06:15:03 |
Czytaj oryginał (ang.) |
| MD or AVTR: Which Is the Better Value Stock Right Now? |
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2024-12-11 14:40:23 |
Czytaj oryginał (ang.) |
| MD or AVTR: Which Is the Better Value Stock Right Now? |
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now? |
zacks.com |
2024-11-25 14:46:26 |
Czytaj oryginał (ang.) |
| Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference |
RADNOR, Pa. , Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Tuesday, December 3, at 9:10 a.m. |
prnewswire.com |
2024-11-20 10:05:00 |
Czytaj oryginał (ang.) |
| Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio, providing researchers across all market segments in t. |
businesswire.com |
2024-11-20 09:30:00 |
Czytaj oryginał (ang.) |
| Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges |
RADNOR, Pa. , Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new flagship Bridgewater Innovation Center. |
prnewswire.com |
2024-11-14 10:05:00 |
Czytaj oryginał (ang.) |
| MD vs. AVTR: Which Stock Is the Better Value Option? |
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2024-11-07 14:40:47 |
Czytaj oryginał (ang.) |
| Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors |
RADNOR, Pa. , Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D. |
prnewswire.com |
2024-11-06 10:05:00 |
Czytaj oryginał (ang.) |
| Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down |
Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance. |
zacks.com |
2024-10-28 17:05:27 |
Czytaj oryginał (ang.) |
| Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript |
Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Douglas Schenkel - Wolfe Research Tycho Peterson - Jefferies Michael Ryskin - Bank of America Vijay Kumar - Evercore ISI Daniel Leonard - UBS Conor McNamara - RBC Capital Markets Daniel Arias - Stifel Rachel Vatnsdal - JP Morgan Luke Sergott - Barclays Tejas Savant - Morgan Stanley Operator Good morning. My name is Emily, and I will be your conference operator today. |
seekingalpha.com |
2024-10-25 18:52:13 |
Czytaj oryginał (ang.) |
| Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates |
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2024-10-25 14:35:36 |
Czytaj oryginał (ang.) |
| Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates |
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago. |
zacks.com |
2024-10-25 12:20:36 |
Czytaj oryginał (ang.) |
| Avantor® Reports Third Quarter 2024 Results |
Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 million Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 Operating cash flow of $244.8 million; free cash flow of $204.0 million RADNOR, Pa. , Oct. 25, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its third fiscal quarter ended September 30, 2024. |
prnewswire.com |
2024-10-25 10:05:00 |
Czytaj oryginał (ang.) |
| Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges |
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing RADNOR, Pa. , Oct. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced an expanded partnership with the National Institute for Bioprocessing Research and Training (NIBRT). |
prnewswire.com |
2024-10-23 12:05:00 |
Czytaj oryginał (ang.) |
| AVTR Stock Flat Following the Close of Divestiture Deal With Audax |
Avantor closes its deal with Audax to divest its clinical services business. |
zacks.com |
2024-10-21 18:30:23 |
Czytaj oryginał (ang.) |
| Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions |
SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) has completed its acquisition of the clinical services business of Avantor, Inc. (NYSE: AVTR) and, in close collaboration with the employees, has re-branded the business as Resonant Clinical Solutions (“Resonant” or “the Company”). Resonant is comprised of three well-respected brands – EPL Archives, MESM, and Therapak. These long-standing brands, whose roots and lineage extend as far back as the 1970s, provide a comprehensi. |
businesswire.com |
2024-10-18 11:35:00 |
Czytaj oryginał (ang.) |
| Avantor® Closes Previously Announced Divestiture of its Clinical Services Business |
RADNOR, Pa. , Oct. 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to Audax Private Equity in a transaction valued at approximately $650 million. |
prnewswire.com |
2024-10-18 11:05:00 |
Czytaj oryginał (ang.) |
| MD vs. AVTR: Which Stock Should Value Investors Buy Now? |
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now? |
zacks.com |
2024-10-02 16:46:34 |
Czytaj oryginał (ang.) |